# Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

> **NCT00437463** · PHASE3 · COMPLETED · sponsor: **Sanofi** · enrollment: 60 (actual)

## Conditions studied

- Glomerulonephritis

## Interventions

- **DRUG:** Ramipril

## Key facts

- **NCT ID:** NCT00437463
- **Lead sponsor:** Sanofi
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-07
- **Primary completion:** 2010-09
- **Final completion:** 2010-09
- **Target enrollment:** 60 (ACTUAL)
- **Last updated:** 2010-11-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00437463

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00437463, "Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00437463. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*